Who invested in Peptimmune?
Peptimmune's investors include New Enterprise Associates, MPM Capital, Prism Venture Management, Hunt Ventures and Vanguard Ventures, and 2 more on record.
United States · Series D startup
3 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$69Mraised across 3 rounds since 2003, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
From a historical funding record
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Peptimmune's investors include New Enterprise Associates, MPM Capital, Prism Venture Management, Hunt Ventures and Vanguard Ventures, and 2 more on record.
Peptimmune has raised $69M across 3 rounds since 2003.
Peptimmune's most recent round was a Series D of $8.9M in Jul 2008.
Peptimmune's largest round on record is $41M (Series A), in Mar 2003.
Peptimmune's first round on record, in Mar 2003, was backed by New Enterprise Associates, MPM Capital and Prism Venture Management and 3 others.
Peptimmune's latest named round is a Series D, in Jul 2008.
Peptimmune is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.